Status:
COMPLETED
Biomarkers in Patients Undergoing Atrial Fibrillation Ablation
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-80 years
Brief Summary
The investigators aim to find biomarkers to determine the success of pulmonary vein isolation for the treatment of atrial fibrillation.
Detailed Description
The investigators perform an observational study in patients undergoing pulmonary vein ablation to treat atrial fibrillation. Additionally, electrophysiological procedures not related to pulmonary vei...
Eligibility Criteria
Inclusion
- patients with atrial fibrillation scheduled for pulmonary vein isolation with either radiofrequency of cryoballoon
- patients scheduled for an electrophysiological study without ablation
- patients with a catheter ablation at the cavotricuspid isthmus for the treatment of right atrial flutter
Exclusion
- patients with concurrent pulmonary vein isolation and ablation of the cavotricuspid isthmus
- Acute myocardial infarction, coronary artery bypass graft surgery or open heart surgery within less than 3 months prior to inclusion
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2019
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03388333
Start Date
January 1 2017
End Date
April 1 2019
Last Update
June 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiology - Electrophysiology, University Heart Centre, University Hospital Hamburg-Eppendorf
Hamburg, Germany, 20246